# Feature Specification: Exploring the Correlation Between Molecular Flexibility and Drug Transport Across Cell Membranes

**Feature Branch**: `001-molecular-flexibility-permeability`  
**Created**: 2024-01-15  
**Status**: Draft  
**Input**: User description: "Exploring the Correlation Between Molecular Flexibility and Drug Transport Across Cell Membranes"

## User Scenarios & Testing *(mandatory)*

### User Story 1 - Retrieve and Preprocess Caco-2 Permeability Dataset (Priority: P1)

A researcher MUST be able to download a raw Caco-2 permeability dataset from ChEMBL, extract molecular structures in SMILES format, filter for valid records, and verify data completeness before analysis begins.

**Why this priority**: This is the foundational data pipeline; without clean input data, no downstream analysis can proceed. The entire research question depends on having a valid dataset with both permeability measurements and corresponding molecular structures.

**Independent Test**: Can be fully tested by executing the data retrieval script and verifying that ≥500 valid records (non-NULL SMILES and logPapp) are produced from a raw batch of ≥600 records.

**Acceptance Scenarios**:

1. **Given** the ChEMBL REST API is accessible, **When** the data retrieval script runs with Caco-2 filter parameters (assay_type = Caco-2), **Then** the script outputs a raw CSV file with ≥600 records containing SMILES and logPapp values
2. **Given** the raw dataset contains ≥600 molecules, **When** the validation script filters for non-NULL SMILES and non-NULL logPapp, **Then** the output contains ≥500 valid records and reports the actual pass rate

---

### User Story 2 - Compute Molecular Flexibility Descriptors and Correlate with Permeability (Priority: P2)

A researcher MUST be able to generate 3D conformer ensembles for each molecule, calculate flexibility descriptors (torsional variance), and compute statistical correlations with permeability values while controlling for confounders.

**Why this priority**: This implements the core research hypothesis; it transforms static structures into dynamic flexibility descriptors and tests the correlation that addresses the knowledge gap, while controlling for known confounders (logP, MW).

**Independent Test**: Can be fully tested by processing a sample of 50 molecules and verifying that flexibility descriptors are computed for ≥450 molecules (from the full set) and at least one correlation coefficient (Pearson or Spearman) is produced with p-values.

**Acceptance Scenarios**:

1. **Given** a validated dataset of ≥500 molecules with SMILES, **When** the conformer generation and flexibility computation pipeline runs, **Then** ≥450 molecules yield valid flexibility descriptors (torsional variance in rad²)
2. **Given** flexibility descriptors and permeability values for ≥450 molecules, **When** the correlation analysis executes, **Then** the output includes Pearson and Spearman correlation coefficients with p-values for the primary flexibility-permeability relationship

---

### User Story 3 - Validate Model Performance and Generate Publication-Quality Visualizations (Priority: P3)

A researcher MUST be able to build a multivariate linear regression model using flexibility descriptors and confounders, validate it with 5-fold cross-validation, and generate visualizations showing the flexibility-permeability relationship with confidence intervals.

**Why this priority**: This completes the research workflow by assessing generalizability and producing results suitable for publication or further investigation, ensuring the flexibility effect is isolated from logP/MW.

**Independent Test**: Can be fully tested by running the full analysis pipeline on the complete dataset and verifying that cross-validation metrics are computed and at least one scatter plot with 95% confidence interval is generated.

**Acceptance Scenarios**:

1. **Given** a completed correlation analysis with ≥450 validated samples, **When** the 5-fold cross-validation multivariate regression runs, **Then** the output includes mean R², RMSE, and MAE across all folds
2. **Given** the flexibility-permeability correlation results, **When** the visualization module executes, **Then** it produces a scatter plot with regression line and 95% confidence interval saved as PNG (metadata dpi ≥ 300)

---

### Edge Cases

- What happens when a molecule's 3D conformer generation fails (e.g., stereochemistry issues, tautomers)? → System logs the failure, skips the molecule, and continues processing; analysis proceeds only if ≥450 valid descriptors are generated
- How does system handle molecules with extreme flexibility values (outliers)? → System flags outliers using the interquartile range method (IQR > 1.5 × Q1) and reports their count separately without excluding them from primary analysis
- What happens when ChEMBL API rate limits are hit during download? → System implements exponential backoff with maximum 3 retries at 5-second intervals before failing gracefully with error message

## Requirements *(mandatory)*

### Functional Requirements

- **FR-001**: System MUST download a raw batch of ≥600 Caco-2 permeability records from ChEMBL REST API (assay_type = Caco-2) containing SMILES and logPapp values (See US-1)
- **FR-002**: System MUST filter the raw dataset to remove records with NULL SMILES or NULL logPapp, report the actual pass rate, and proceed only if ≥500 valid records remain (See US-1)
- **FR-003**: System MUST generate 3D conformer ensembles (size ≥ 50, energy window ≤ 10 kcal/mol) using RDKit for ≥450 molecules from the valid dataset (See US-2)
- **FR-004**: System MUST compute flexibility descriptors defined as torsional variance (bond, angle, dihedral) in units of radians squared (rad²) for each molecule (See US-2)
- **FR-005**: System MUST perform Pearson and Spearman correlation analysis between each flexibility descriptor and logPapp with p-value calculation (See US-2)
- **FR-006**: System MUST apply Benjamini-Hochberg false discovery rate correction whenever N > 1 flexibility descriptors are tested (See US-2)
- **FR-007**: System MUST build a multivariate linear regression model using flexibility descriptors and confounders (logP, MW, PSA) and execute 5-fold cross-validation (See US-3)
- **FR-008**: System MUST generate scatter plot visualization with regression line and 95% confidence interval in PNG format with metadata dpi ≥ 300 (See US-3)
- **FR-009**: System MUST flag correlation thresholds as associational (not causal) in all output documentation and visualizations (See US-2)
- **FR-010**: System MUST filter ChEMBL data for standardized assay protocols (standard_type = MEASUREMENT) and report the number of excluded records due to protocol heterogeneity (See US-1)

### Key Entities

- **Molecule**: Represents a drug-like compound with attributes: SMILES string, molecular weight, Caco-2 logPapp value, 3D conformer ensemble
- **FlexibilityDescriptor**: Represents computed flexibility metric with attributes: torsional variance (bond, angle, dihedral in rad²), sampling parameters (ensemble size, energy window)
- **CorrelationResult**: Represents statistical relationship with attributes: correlation coefficient (r), p-value, confidence interval, method (Pearson/Spearman)
- **ModelPerformance**: Represents cross-validation metrics with attributes: mean R², RMSE, MAE, fold-specific scores (5 values), confounder coefficients

## Success Criteria *(mandatory)*

### Measurable Outcomes

> Planning docs state *what* will be measured and the *source/reference* it is
> measured against; defer specific empirical values (counts, dataset sizes,
> measured quantities, percentages) to the implementation/research phase.

- **SC-001**: Dataset completeness rate is measured against the actual pass rate reported after filtering (See US-1)
- **SC-002**: Conformer generation success rate is measured against a minimum threshold of valid descriptors. (See US-2)
- **SC-003**: Correlation analysis is measured against completeness of reporting (r, p-value, FDR-corrected q-value for all descriptors) (See US-2)
- **SC-004**: Model generalizability is measured against k-fold cross-validation R² variance (standard deviation across folds) for the multivariate model (See US-3)
- **SC-005**: Computational feasibility is measured against ≤6 hours total runtime on CPU-only GitHub Actions runner (See US-1, US-2, US-3)
- **SC-006**: Protocol consistency is measured against the count of excluded records due to assay heterogeneity (See US-1)

## Assumptions

- ChEMBL database contains ≥600 raw drug-like molecules with both SMILES structures and Caco-2 logPapp permeability values accessible via REST API
- RDKit conformer generation runs within Limited RAM capacity for the full dataset (sample to ≤1000 molecules if needed)
- Torsional variance calculation using RDKit completes within 6 hours on Multiple CPU cores without GPU acceleration
- Caco-2 permeability measurements in ChEMBL are filtered for 'standard_type = MEASUREMENT' to ensure consistency
- Molecular flexibility metrics (torsional variance) are computed in default double precision (no CUDA/GPU required)
- Correlation findings are framed as associational relationships (observational design, no randomization)
- Benjamini-Hochberg false discovery rate correction uses q < 0.05 threshold for multiple hypothesis testing
- All molecular descriptors use validated computational methods from peer-reviewed literature (no novel unvalidated metrics)
- Predictor collinearity among flexibility descriptors is diagnosed using variance inflation factor (VIF) and reported if VIF > 5 for any descriptor pair
- Sample size power analysis is deferred to implementation phase; analysis proceeds with available dataset and reports power limitation if N < 200